nodes	percent_of_prediction	percent_of_DWPC	metapath
SIMEPREVIR—CYP3A4—prostate cancer	0.156	1	CbGaD
SIMEPREVIR—SLCO1B1—Cabazitaxel—prostate cancer	0.0551	0.0905	CbGbCtD
SIMEPREVIR—SLCO1B1—Estrone—prostate cancer	0.0538	0.0884	CbGbCtD
SIMEPREVIR—ALB—Abiraterone—prostate cancer	0.0408	0.067	CbGbCtD
SIMEPREVIR—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0352	0.0579	CbGbCtD
SIMEPREVIR—SLCO1B1—Estradiol—prostate cancer	0.0309	0.0508	CbGbCtD
SIMEPREVIR—ALB—Estrone—prostate cancer	0.0295	0.0484	CbGbCtD
SIMEPREVIR—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0294	0.0482	CbGbCtD
SIMEPREVIR—CYP1A2—Flutamide—prostate cancer	0.0244	0.0401	CbGbCtD
SIMEPREVIR—ABCB1—Estramustine—prostate cancer	0.0239	0.0393	CbGbCtD
SIMEPREVIR—CYP1A2—Estrone—prostate cancer	0.0176	0.029	CbGbCtD
SIMEPREVIR—ALB—Estradiol—prostate cancer	0.0169	0.0278	CbGbCtD
SIMEPREVIR—ABCB1—Cabazitaxel—prostate cancer	0.0158	0.0259	CbGbCtD
SIMEPREVIR—CYP3A4—Bicalutamide—prostate cancer	0.0154	0.0253	CbGbCtD
SIMEPREVIR—ABCB1—Estrone—prostate cancer	0.0154	0.0253	CbGbCtD
SIMEPREVIR—ALB—Prednisone—prostate cancer	0.0146	0.0239	CbGbCtD
SIMEPREVIR—CYP3A4—Estramustine—prostate cancer	0.0143	0.0236	CbGbCtD
SIMEPREVIR—ABCB1—Ethinyl Estradiol—prostate cancer	0.0137	0.0226	CbGbCtD
SIMEPREVIR—CYP3A4—Flutamide—prostate cancer	0.0128	0.021	CbGbCtD
SIMEPREVIR—CYP3A4—Abiraterone—prostate cancer	0.0128	0.021	CbGbCtD
SIMEPREVIR—CYP1A2—Conjugated Estrogens—prostate cancer	0.0115	0.019	CbGbCtD
SIMEPREVIR—CYP1A2—Estradiol—prostate cancer	0.0101	0.0166	CbGbCtD
SIMEPREVIR—ABCB1—Conjugated Estrogens—prostate cancer	0.0101	0.0166	CbGbCtD
SIMEPREVIR—CYP3A4—Cabazitaxel—prostate cancer	0.00945	0.0155	CbGbCtD
SIMEPREVIR—CYP3A4—Estrone—prostate cancer	0.00924	0.0152	CbGbCtD
SIMEPREVIR—ABCB1—Mitoxantrone—prostate cancer	0.00917	0.0151	CbGbCtD
SIMEPREVIR—ABCB1—Estradiol—prostate cancer	0.00886	0.0145	CbGbCtD
SIMEPREVIR—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00823	0.0135	CbGbCtD
SIMEPREVIR—ABCB1—Prednisone—prostate cancer	0.00761	0.0125	CbGbCtD
SIMEPREVIR—CYP1A2—Etoposide—prostate cancer	0.00661	0.0109	CbGbCtD
SIMEPREVIR—CYP3A4—Conjugated Estrogens—prostate cancer	0.00604	0.00993	CbGbCtD
SIMEPREVIR—ABCB1—Etoposide—prostate cancer	0.00578	0.0095	CbGbCtD
SIMEPREVIR—CYP3A4—Mitoxantrone—prostate cancer	0.00549	0.00903	CbGbCtD
SIMEPREVIR—CYP3A4—Estradiol—prostate cancer	0.00531	0.00872	CbGbCtD
SIMEPREVIR—ABCB1—Docetaxel—prostate cancer	0.00529	0.00869	CbGbCtD
SIMEPREVIR—CYP3A4—Prednisone—prostate cancer	0.00456	0.0075	CbGbCtD
SIMEPREVIR—ABCB1—Doxorubicin—prostate cancer	0.00394	0.00648	CbGbCtD
SIMEPREVIR—CYP3A4—Etoposide—prostate cancer	0.00346	0.00569	CbGbCtD
SIMEPREVIR—CYP3A4—Docetaxel—prostate cancer	0.00317	0.00521	CbGbCtD
SIMEPREVIR—CTSS—prostate gland—prostate cancer	0.0027	0.121	CbGeAlD
SIMEPREVIR—CYP1A2—urine—prostate cancer	0.00259	0.116	CbGeAlD
SIMEPREVIR—CYP3A4—Doxorubicin—prostate cancer	0.00236	0.00388	CbGbCtD
SIMEPREVIR—CTSS—seminal vesicle—prostate cancer	0.00229	0.102	CbGeAlD
SIMEPREVIR—CYP3A4—urine—prostate cancer	0.00188	0.0838	CbGeAlD
SIMEPREVIR—CTSS—renal system—prostate cancer	0.00184	0.0822	CbGeAlD
SIMEPREVIR—CTSS—urethra—prostate cancer	0.00181	0.0808	CbGeAlD
SIMEPREVIR—CTSS—bone marrow—prostate cancer	0.00139	0.0622	CbGeAlD
SIMEPREVIR—SLCO1B1—renal system—prostate cancer	0.00119	0.0532	CbGeAlD
SIMEPREVIR—CTSS—testis—prostate cancer	0.00119	0.0532	CbGeAlD
SIMEPREVIR—CTSS—lymph node—prostate cancer	0.000864	0.0385	CbGeAlD
SIMEPREVIR—CYP1A2—renal system—prostate cancer	0.000635	0.0283	CbGeAlD
SIMEPREVIR—ALB—testis—prostate cancer	0.000624	0.0278	CbGeAlD
SIMEPREVIR—Hepatobiliary disease—Conjugated Estrogens—prostate cancer	0.000497	0.00472	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Capecitabine—prostate cancer	0.000496	0.00471	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Cabazitaxel—prostate cancer	0.00049	0.00465	CcSEcCtD
SIMEPREVIR—Fatigue—Cabazitaxel—prostate cancer	0.000489	0.00464	CcSEcCtD
SIMEPREVIR—Constipation—Cabazitaxel—prostate cancer	0.000485	0.00461	CcSEcCtD
SIMEPREVIR—Asthenia—Nilutamide—prostate cancer	0.000484	0.00459	CcSEcCtD
SIMEPREVIR—Infection—Bicalutamide—prostate cancer	0.000484	0.00459	CcSEcCtD
SIMEPREVIR—Asthenia—Flutamide—prostate cancer	0.000482	0.00457	CcSEcCtD
SIMEPREVIR—Rash—Estramustine—prostate cancer	0.000479	0.00455	CcSEcCtD
SIMEPREVIR—Dermatitis—Estramustine—prostate cancer	0.000479	0.00454	CcSEcCtD
SIMEPREVIR—ABCB1—prostate gland—prostate cancer	0.000477	0.0213	CbGeAlD
SIMEPREVIR—Pruritus—Nilutamide—prostate cancer	0.000477	0.00453	CcSEcCtD
SIMEPREVIR—Headache—Estramustine—prostate cancer	0.000476	0.00452	CcSEcCtD
SIMEPREVIR—Pruritus—Flutamide—prostate cancer	0.000475	0.00451	CcSEcCtD
SIMEPREVIR—Skin disorder—Bicalutamide—prostate cancer	0.000473	0.00449	CcSEcCtD
SIMEPREVIR—Rash—Abiraterone—prostate cancer	0.000465	0.00442	CcSEcCtD
SIMEPREVIR—Dermatitis—Abiraterone—prostate cancer	0.000465	0.00441	CcSEcCtD
SIMEPREVIR—CYP3A4—renal system—prostate cancer	0.000459	0.0205	CbGeAlD
SIMEPREVIR—Rash—Estrone—prostate cancer	0.000458	0.00434	CcSEcCtD
SIMEPREVIR—Dermatitis—Estrone—prostate cancer	0.000457	0.00434	CcSEcCtD
SIMEPREVIR—Headache—Estrone—prostate cancer	0.000455	0.00432	CcSEcCtD
SIMEPREVIR—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.000455	0.00431	CcSEcCtD
SIMEPREVIR—ALB—lymph node—prostate cancer	0.000452	0.0202	CbGeAlD
SIMEPREVIR—Nausea—Estramustine—prostate cancer	0.000451	0.00428	CcSEcCtD
SIMEPREVIR—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.000448	0.00425	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Bicalutamide—prostate cancer	0.000443	0.00421	CcSEcCtD
SIMEPREVIR—Insomnia—Bicalutamide—prostate cancer	0.00044	0.00418	CcSEcCtD
SIMEPREVIR—Dyspnoea—Bicalutamide—prostate cancer	0.000434	0.00412	CcSEcCtD
SIMEPREVIR—Asthenia—Degarelix—prostate cancer	0.000432	0.0041	CcSEcCtD
SIMEPREVIR—Nausea—Estrone—prostate cancer	0.000431	0.00409	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Estradiol—prostate cancer	0.000431	0.00409	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—prostate cancer	0.000426	0.00405	CcSEcCtD
SIMEPREVIR—Pruritus—Degarelix—prostate cancer	0.000426	0.00404	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Conjugated Estrogens—prostate cancer	0.000425	0.00404	CcSEcCtD
SIMEPREVIR—Rash—Nilutamide—prostate cancer	0.000425	0.00403	CcSEcCtD
SIMEPREVIR—Dermatitis—Nilutamide—prostate cancer	0.000425	0.00403	CcSEcCtD
SIMEPREVIR—Rash—Flutamide—prostate cancer	0.000423	0.00402	CcSEcCtD
SIMEPREVIR—Dermatitis—Flutamide—prostate cancer	0.000423	0.00401	CcSEcCtD
SIMEPREVIR—Headache—Nilutamide—prostate cancer	0.000422	0.00401	CcSEcCtD
SIMEPREVIR—Headache—Flutamide—prostate cancer	0.000421	0.00399	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.00042	0.00399	CcSEcCtD
SIMEPREVIR—Fatigue—Bicalutamide—prostate cancer	0.00042	0.00398	CcSEcCtD
SIMEPREVIR—Constipation—Bicalutamide—prostate cancer	0.000416	0.00395	CcSEcCtD
SIMEPREVIR—Infection—Ethinyl Estradiol—prostate cancer	0.000409	0.00388	CcSEcCtD
SIMEPREVIR—Asthenia—Cabazitaxel—prostate cancer	0.000407	0.00386	CcSEcCtD
SIMEPREVIR—ABCB1—seminal vesicle—prostate cancer	0.000404	0.018	CbGeAlD
SIMEPREVIR—Nausea—Nilutamide—prostate cancer	0.0004	0.0038	CcSEcCtD
SIMEPREVIR—Skin disorder—Ethinyl Estradiol—prostate cancer	0.0004	0.00379	CcSEcCtD
SIMEPREVIR—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000399	0.00379	CcSEcCtD
SIMEPREVIR—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000399	0.00379	CcSEcCtD
SIMEPREVIR—Nausea—Flutamide—prostate cancer	0.000399	0.00378	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Estradiol—prostate cancer	0.000398	0.00378	CcSEcCtD
SIMEPREVIR—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000397	0.00377	CcSEcCtD
SIMEPREVIR—Photosensitivity—Capecitabine—prostate cancer	0.000388	0.00368	CcSEcCtD
SIMEPREVIR—Anaemia—Goserelin—prostate cancer	0.000383	0.00364	CcSEcCtD
SIMEPREVIR—Rash—Degarelix—prostate cancer	0.00038	0.0036	CcSEcCtD
SIMEPREVIR—Dermatitis—Degarelix—prostate cancer	0.000379	0.0036	CcSEcCtD
SIMEPREVIR—Headache—Degarelix—prostate cancer	0.000377	0.00358	CcSEcCtD
SIMEPREVIR—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000376	0.00357	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Epirubicin—prostate cancer	0.000359	0.00341	CcSEcCtD
SIMEPREVIR—Nausea—Degarelix—prostate cancer	0.000358	0.0034	CcSEcCtD
SIMEPREVIR—Headache—Cabazitaxel—prostate cancer	0.000355	0.00337	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.000355	0.00337	CcSEcCtD
SIMEPREVIR—Fatigue—Ethinyl Estradiol—prostate cancer	0.000355	0.00337	CcSEcCtD
SIMEPREVIR—Myalgia—Goserelin—prostate cancer	0.000353	0.00335	CcSEcCtD
SIMEPREVIR—Constipation—Ethinyl Estradiol—prostate cancer	0.000352	0.00334	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Goserelin—prostate cancer	0.000351	0.00333	CcSEcCtD
SIMEPREVIR—ABCB1—epithelium—prostate cancer	0.000351	0.0156	CbGeAlD
SIMEPREVIR—Myalgia—Conjugated Estrogens—prostate cancer	0.00035	0.00332	CcSEcCtD
SIMEPREVIR—Asthenia—Bicalutamide—prostate cancer	0.000349	0.00331	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—prostate cancer	0.000347	0.0033	CcSEcCtD
SIMEPREVIR—Blood bilirubin increased—Epirubicin—prostate cancer	0.000346	0.00328	CcSEcCtD
SIMEPREVIR—Pruritus—Bicalutamide—prostate cancer	0.000344	0.00327	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Estradiol—prostate cancer	0.000341	0.00323	CcSEcCtD
SIMEPREVIR—Nausea—Cabazitaxel—prostate cancer	0.000337	0.0032	CcSEcCtD
SIMEPREVIR—Infection—Goserelin—prostate cancer	0.000336	0.00319	CcSEcCtD
SIMEPREVIR—Infection—Conjugated Estrogens—prostate cancer	0.000333	0.00316	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Doxorubicin—prostate cancer	0.000333	0.00316	CcSEcCtD
SIMEPREVIR—Skin disorder—Goserelin—prostate cancer	0.000329	0.00312	CcSEcCtD
SIMEPREVIR—Skin disorder—Conjugated Estrogens—prostate cancer	0.000326	0.00309	CcSEcCtD
SIMEPREVIR—ABCB1—renal system—prostate cancer	0.000325	0.0145	CbGeAlD
SIMEPREVIR—Blood bilirubin increased—Doxorubicin—prostate cancer	0.00032	0.00303	CcSEcCtD
SIMEPREVIR—ABCB1—urethra—prostate cancer	0.000319	0.0143	CbGeAlD
SIMEPREVIR—Hepatobiliary disease—Etoposide—prostate cancer	0.000308	0.00293	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Goserelin—prostate cancer	0.000308	0.00293	CcSEcCtD
SIMEPREVIR—Rash—Bicalutamide—prostate cancer	0.000307	0.00291	CcSEcCtD
SIMEPREVIR—Dermatitis—Bicalutamide—prostate cancer	0.000307	0.00291	CcSEcCtD
SIMEPREVIR—Insomnia—Goserelin—prostate cancer	0.000306	0.00291	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.000306	0.0029	CcSEcCtD
SIMEPREVIR—Headache—Bicalutamide—prostate cancer	0.000305	0.00289	CcSEcCtD
SIMEPREVIR—Insomnia—Conjugated Estrogens—prostate cancer	0.000303	0.00288	CcSEcCtD
SIMEPREVIR—Dyspnoea—Goserelin—prostate cancer	0.000302	0.00287	CcSEcCtD
SIMEPREVIR—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000299	0.00284	CcSEcCtD
SIMEPREVIR—Asthenia—Ethinyl Estradiol—prostate cancer	0.000295	0.0028	CcSEcCtD
SIMEPREVIR—Fatigue—Goserelin—prostate cancer	0.000292	0.00277	CcSEcCtD
SIMEPREVIR—Pruritus—Ethinyl Estradiol—prostate cancer	0.000291	0.00276	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.00029	0.00275	CcSEcCtD
SIMEPREVIR—Constipation—Goserelin—prostate cancer	0.00029	0.00275	CcSEcCtD
SIMEPREVIR—Fatigue—Conjugated Estrogens—prostate cancer	0.000289	0.00274	CcSEcCtD
SIMEPREVIR—Nausea—Bicalutamide—prostate cancer	0.000289	0.00274	CcSEcCtD
SIMEPREVIR—Constipation—Conjugated Estrogens—prostate cancer	0.000287	0.00272	CcSEcCtD
SIMEPREVIR—Anaemia—Mitoxantrone—prostate cancer	0.000283	0.00269	CcSEcCtD
SIMEPREVIR—Myalgia—Estradiol—prostate cancer	0.00028	0.00266	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000278	0.00264	CcSEcCtD
SIMEPREVIR—Photosensitivity—Epirubicin—prostate cancer	0.00027	0.00256	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Capecitabine—prostate cancer	0.000269	0.00255	CcSEcCtD
SIMEPREVIR—Infection—Estradiol—prostate cancer	0.000267	0.00253	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Etoposide—prostate cancer	0.000264	0.0025	CcSEcCtD
SIMEPREVIR—Myalgia—Mitoxantrone—prostate cancer	0.000261	0.00248	CcSEcCtD
SIMEPREVIR—Skin disorder—Estradiol—prostate cancer	0.000261	0.00247	CcSEcCtD
SIMEPREVIR—Rash—Ethinyl Estradiol—prostate cancer	0.000259	0.00246	CcSEcCtD
SIMEPREVIR—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000259	0.00246	CcSEcCtD
SIMEPREVIR—Headache—Ethinyl Estradiol—prostate cancer	0.000258	0.00245	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Docetaxel—prostate cancer	0.000256	0.00243	CcSEcCtD
SIMEPREVIR—Photosensitivity—Doxorubicin—prostate cancer	0.00025	0.00237	CcSEcCtD
SIMEPREVIR—Infection—Mitoxantrone—prostate cancer	0.000248	0.00236	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Capecitabine—prostate cancer	0.000248	0.00236	CcSEcCtD
SIMEPREVIR—ABCB1—bone marrow—prostate cancer	0.000246	0.011	CbGeAlD
SIMEPREVIR—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000245	0.00232	CcSEcCtD
SIMEPREVIR—Nausea—Ethinyl Estradiol—prostate cancer	0.000244	0.00232	CcSEcCtD
SIMEPREVIR—Asthenia—Goserelin—prostate cancer	0.000243	0.00231	CcSEcCtD
SIMEPREVIR—Skin disorder—Mitoxantrone—prostate cancer	0.000243	0.00231	CcSEcCtD
SIMEPREVIR—Insomnia—Estradiol—prostate cancer	0.000243	0.0023	CcSEcCtD
SIMEPREVIR—Asthenia—Conjugated Estrogens—prostate cancer	0.000241	0.00228	CcSEcCtD
SIMEPREVIR—Pruritus—Goserelin—prostate cancer	0.00024	0.00227	CcSEcCtD
SIMEPREVIR—Dyspnoea—Estradiol—prostate cancer	0.000239	0.00227	CcSEcCtD
SIMEPREVIR—Pruritus—Conjugated Estrogens—prostate cancer	0.000237	0.00225	CcSEcCtD
SIMEPREVIR—Anaemia—Etoposide—prostate cancer	0.000236	0.00224	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Estradiol—prostate cancer	0.000232	0.0022	CcSEcCtD
SIMEPREVIR—Fatigue—Estradiol—prostate cancer	0.000231	0.0022	CcSEcCtD
SIMEPREVIR—Constipation—Estradiol—prostate cancer	0.00023	0.00218	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000228	0.00216	CcSEcCtD
SIMEPREVIR—Dyspnoea—Mitoxantrone—prostate cancer	0.000223	0.00212	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Docetaxel—prostate cancer	0.000219	0.00208	CcSEcCtD
SIMEPREVIR—Fatigue—Mitoxantrone—prostate cancer	0.000216	0.00205	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000216	0.00205	CcSEcCtD
SIMEPREVIR—Constipation—Mitoxantrone—prostate cancer	0.000214	0.00203	CcSEcCtD
SIMEPREVIR—Rash—Goserelin—prostate cancer	0.000213	0.00203	CcSEcCtD
SIMEPREVIR—Dermatitis—Goserelin—prostate cancer	0.000213	0.00202	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Capecitabine—prostate cancer	0.000212	0.00202	CcSEcCtD
SIMEPREVIR—Headache—Goserelin—prostate cancer	0.000212	0.00201	CcSEcCtD
SIMEPREVIR—Rash—Conjugated Estrogens—prostate cancer	0.000211	0.00201	CcSEcCtD
SIMEPREVIR—Dermatitis—Conjugated Estrogens—prostate cancer	0.000211	0.00201	CcSEcCtD
SIMEPREVIR—ABCB1—testis—prostate cancer	0.00021	0.00938	CbGeAlD
SIMEPREVIR—Headache—Conjugated Estrogens—prostate cancer	0.00021	0.00199	CcSEcCtD
SIMEPREVIR—Infection—Etoposide—prostate cancer	0.000207	0.00196	CcSEcCtD
SIMEPREVIR—Skin disorder—Etoposide—prostate cancer	0.000202	0.00192	CcSEcCtD
SIMEPREVIR—Nausea—Goserelin—prostate cancer	0.000201	0.00191	CcSEcCtD
SIMEPREVIR—Nausea—Conjugated Estrogens—prostate cancer	0.000199	0.00189	CcSEcCtD
SIMEPREVIR—Anaemia—Docetaxel—prostate cancer	0.000196	0.00186	CcSEcCtD
SIMEPREVIR—Asthenia—Estradiol—prostate cancer	0.000193	0.00183	CcSEcCtD
SIMEPREVIR—Pruritus—Estradiol—prostate cancer	0.00019	0.0018	CcSEcCtD
SIMEPREVIR—Anaemia—Capecitabine—prostate cancer	0.00019	0.0018	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Epirubicin—prostate cancer	0.000187	0.00178	CcSEcCtD
SIMEPREVIR—Dyspnoea—Etoposide—prostate cancer	0.000185	0.00176	CcSEcCtD
SIMEPREVIR—Myalgia—Docetaxel—prostate cancer	0.00018	0.00171	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Etoposide—prostate cancer	0.00018	0.0017	CcSEcCtD
SIMEPREVIR—Asthenia—Mitoxantrone—prostate cancer	0.000179	0.0017	CcSEcCtD
SIMEPREVIR—Fatigue—Etoposide—prostate cancer	0.000179	0.0017	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000179	0.0017	CcSEcCtD
SIMEPREVIR—Constipation—Etoposide—prostate cancer	0.000178	0.00169	CcSEcCtD
SIMEPREVIR—Myalgia—Capecitabine—prostate cancer	0.000175	0.00166	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000173	0.00165	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000173	0.00164	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Epirubicin—prostate cancer	0.000173	0.00164	CcSEcCtD
SIMEPREVIR—Infection—Docetaxel—prostate cancer	0.000172	0.00163	CcSEcCtD
SIMEPREVIR—Rash—Estradiol—prostate cancer	0.000169	0.00161	CcSEcCtD
SIMEPREVIR—Dermatitis—Estradiol—prostate cancer	0.000169	0.0016	CcSEcCtD
SIMEPREVIR—Anaemia—Prednisone—prostate cancer	0.000169	0.0016	CcSEcCtD
SIMEPREVIR—Headache—Estradiol—prostate cancer	0.000168	0.0016	CcSEcCtD
SIMEPREVIR—Skin disorder—Docetaxel—prostate cancer	0.000168	0.00159	CcSEcCtD
SIMEPREVIR—Infection—Capecitabine—prostate cancer	0.000166	0.00158	CcSEcCtD
SIMEPREVIR—Skin disorder—Capecitabine—prostate cancer	0.000163	0.00154	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Doxorubicin—prostate cancer	0.00016	0.00152	CcSEcCtD
SIMEPREVIR—Nausea—Estradiol—prostate cancer	0.000159	0.00151	CcSEcCtD
SIMEPREVIR—Rash—Mitoxantrone—prostate cancer	0.000158	0.0015	CcSEcCtD
SIMEPREVIR—Dermatitis—Mitoxantrone—prostate cancer	0.000158	0.0015	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000158	0.00149	CcSEcCtD
SIMEPREVIR—Headache—Mitoxantrone—prostate cancer	0.000157	0.00149	CcSEcCtD
SIMEPREVIR—Insomnia—Docetaxel—prostate cancer	0.000156	0.00148	CcSEcCtD
SIMEPREVIR—Myalgia—Prednisone—prostate cancer	0.000156	0.00148	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000154	0.00147	CcSEcCtD
SIMEPREVIR—Dyspnoea—Docetaxel—prostate cancer	0.000154	0.00146	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000153	0.00145	CcSEcCtD
SIMEPREVIR—ABCB1—lymph node—prostate cancer	0.000152	0.0068	CbGeAlD
SIMEPREVIR—Insomnia—Capecitabine—prostate cancer	0.000151	0.00144	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000149	0.00142	CcSEcCtD
SIMEPREVIR—Asthenia—Etoposide—prostate cancer	0.000149	0.00142	CcSEcCtD
SIMEPREVIR—Dyspnoea—Capecitabine—prostate cancer	0.000149	0.00142	CcSEcCtD
SIMEPREVIR—Fatigue—Docetaxel—prostate cancer	0.000149	0.00141	CcSEcCtD
SIMEPREVIR—Nausea—Mitoxantrone—prostate cancer	0.000149	0.00141	CcSEcCtD
SIMEPREVIR—Infection—Prednisone—prostate cancer	0.000148	0.00141	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Epirubicin—prostate cancer	0.000148	0.0014	CcSEcCtD
SIMEPREVIR—Constipation—Docetaxel—prostate cancer	0.000148	0.0014	CcSEcCtD
SIMEPREVIR—Pruritus—Etoposide—prostate cancer	0.000147	0.0014	CcSEcCtD
SIMEPREVIR—Skin disorder—Prednisone—prostate cancer	0.000145	0.00137	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000145	0.00137	CcSEcCtD
SIMEPREVIR—Fatigue—Capecitabine—prostate cancer	0.000144	0.00137	CcSEcCtD
SIMEPREVIR—Constipation—Capecitabine—prostate cancer	0.000143	0.00136	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Doxorubicin—prostate cancer	0.000137	0.0013	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000136	0.00129	CcSEcCtD
SIMEPREVIR—Insomnia—Prednisone—prostate cancer	0.000135	0.00128	CcSEcCtD
SIMEPREVIR—Anaemia—Epirubicin—prostate cancer	0.000132	0.00125	CcSEcCtD
SIMEPREVIR—Rash—Etoposide—prostate cancer	0.000131	0.00124	CcSEcCtD
SIMEPREVIR—Dermatitis—Etoposide—prostate cancer	0.000131	0.00124	CcSEcCtD
SIMEPREVIR—Headache—Etoposide—prostate cancer	0.00013	0.00124	CcSEcCtD
SIMEPREVIR—Fatigue—Prednisone—prostate cancer	0.000129	0.00122	CcSEcCtD
SIMEPREVIR—Constipation—Prednisone—prostate cancer	0.000128	0.00121	CcSEcCtD
SIMEPREVIR—Asthenia—Docetaxel—prostate cancer	0.000124	0.00118	CcSEcCtD
SIMEPREVIR—Nausea—Etoposide—prostate cancer	0.000124	0.00117	CcSEcCtD
SIMEPREVIR—Pruritus—Docetaxel—prostate cancer	0.000122	0.00116	CcSEcCtD
SIMEPREVIR—Anaemia—Doxorubicin—prostate cancer	0.000122	0.00116	CcSEcCtD
SIMEPREVIR—Myalgia—Epirubicin—prostate cancer	0.000122	0.00115	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000121	0.00115	CcSEcCtD
SIMEPREVIR—Asthenia—Capecitabine—prostate cancer	0.00012	0.00114	CcSEcCtD
SIMEPREVIR—Pruritus—Capecitabine—prostate cancer	0.000118	0.00112	CcSEcCtD
SIMEPREVIR—Infection—Epirubicin—prostate cancer	0.000116	0.0011	CcSEcCtD
SIMEPREVIR—Skin disorder—Epirubicin—prostate cancer	0.000113	0.00108	CcSEcCtD
SIMEPREVIR—Myalgia—Doxorubicin—prostate cancer	0.000113	0.00107	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000112	0.00106	CcSEcCtD
SIMEPREVIR—Rash—Docetaxel—prostate cancer	0.000109	0.00103	CcSEcCtD
SIMEPREVIR—Dermatitis—Docetaxel—prostate cancer	0.000109	0.00103	CcSEcCtD
SIMEPREVIR—Headache—Docetaxel—prostate cancer	0.000108	0.00103	CcSEcCtD
SIMEPREVIR—Infection—Doxorubicin—prostate cancer	0.000107	0.00102	CcSEcCtD
SIMEPREVIR—Asthenia—Prednisone—prostate cancer	0.000107	0.00102	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000106	0.00101	CcSEcCtD
SIMEPREVIR—Rash—Capecitabine—prostate cancer	0.000106	0.001	CcSEcCtD
SIMEPREVIR—Pruritus—Prednisone—prostate cancer	0.000105	0.001	CcSEcCtD
SIMEPREVIR—Insomnia—Epirubicin—prostate cancer	0.000105	0.001	CcSEcCtD
SIMEPREVIR—Dermatitis—Capecitabine—prostate cancer	0.000105	0.001	CcSEcCtD
SIMEPREVIR—Headache—Capecitabine—prostate cancer	0.000105	0.000995	CcSEcCtD
SIMEPREVIR—Skin disorder—Doxorubicin—prostate cancer	0.000105	0.000995	CcSEcCtD
SIMEPREVIR—Dyspnoea—Epirubicin—prostate cancer	0.000104	0.000987	CcSEcCtD
SIMEPREVIR—Nausea—Docetaxel—prostate cancer	0.000103	0.000975	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000101	0.000956	CcSEcCtD
SIMEPREVIR—Fatigue—Epirubicin—prostate cancer	0.000101	0.000954	CcSEcCtD
SIMEPREVIR—Constipation—Epirubicin—prostate cancer	9.97e-05	0.000946	CcSEcCtD
SIMEPREVIR—Nausea—Capecitabine—prostate cancer	9.94e-05	0.000944	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Doxorubicin—prostate cancer	9.83e-05	0.000933	CcSEcCtD
SIMEPREVIR—Insomnia—Doxorubicin—prostate cancer	9.76e-05	0.000926	CcSEcCtD
SIMEPREVIR—Dyspnoea—Doxorubicin—prostate cancer	9.62e-05	0.000913	CcSEcCtD
SIMEPREVIR—Rash—Prednisone—prostate cancer	9.4e-05	0.000892	CcSEcCtD
SIMEPREVIR—Dermatitis—Prednisone—prostate cancer	9.39e-05	0.000891	CcSEcCtD
SIMEPREVIR—Headache—Prednisone—prostate cancer	9.34e-05	0.000887	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Doxorubicin—prostate cancer	9.32e-05	0.000884	CcSEcCtD
SIMEPREVIR—Fatigue—Doxorubicin—prostate cancer	9.3e-05	0.000883	CcSEcCtD
SIMEPREVIR—Constipation—Doxorubicin—prostate cancer	9.23e-05	0.000876	CcSEcCtD
SIMEPREVIR—Nausea—Prednisone—prostate cancer	8.86e-05	0.000841	CcSEcCtD
SIMEPREVIR—Asthenia—Epirubicin—prostate cancer	8.37e-05	0.000794	CcSEcCtD
SIMEPREVIR—Pruritus—Epirubicin—prostate cancer	8.25e-05	0.000783	CcSEcCtD
SIMEPREVIR—Asthenia—Doxorubicin—prostate cancer	7.74e-05	0.000735	CcSEcCtD
SIMEPREVIR—Pruritus—Doxorubicin—prostate cancer	7.63e-05	0.000725	CcSEcCtD
SIMEPREVIR—Rash—Epirubicin—prostate cancer	7.35e-05	0.000698	CcSEcCtD
SIMEPREVIR—Dermatitis—Epirubicin—prostate cancer	7.35e-05	0.000697	CcSEcCtD
SIMEPREVIR—Headache—Epirubicin—prostate cancer	7.31e-05	0.000693	CcSEcCtD
SIMEPREVIR—Nausea—Epirubicin—prostate cancer	6.93e-05	0.000657	CcSEcCtD
SIMEPREVIR—Rash—Doxorubicin—prostate cancer	6.8e-05	0.000646	CcSEcCtD
SIMEPREVIR—Dermatitis—Doxorubicin—prostate cancer	6.8e-05	0.000645	CcSEcCtD
SIMEPREVIR—Headache—Doxorubicin—prostate cancer	6.76e-05	0.000642	CcSEcCtD
SIMEPREVIR—Nausea—Doxorubicin—prostate cancer	6.41e-05	0.000608	CcSEcCtD
SIMEPREVIR—ALB—Metabolism—PRKACB—prostate cancer	6.67e-06	6.17e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	6.61e-06	6.12e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NCOA3—prostate cancer	6.6e-06	6.11e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP17A1—prostate cancer	6.6e-06	6.11e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTA2—prostate cancer	6.59e-06	6.1e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—JAK2—prostate cancer	6.56e-06	6.07e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.53e-06	6.04e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SULT1A1—prostate cancer	6.51e-06	6.03e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ABCG5—prostate cancer	6.51e-06	6.03e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.51e-06	6.02e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ACSL4—prostate cancer	6.4e-06	5.93e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HSD17B3—prostate cancer	6.4e-06	5.93e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTA1—prostate cancer	6.36e-06	5.89e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CAV1—prostate cancer	6.34e-06	5.86e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—HPGDS—prostate cancer	6.3e-06	5.83e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTO1—prostate cancer	6.29e-06	5.82e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NAT2—prostate cancer	6.29e-06	5.82e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—HSD3B2—prostate cancer	6.29e-06	5.82e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NCOA2—prostate cancer	6.29e-06	5.82e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP2C19—prostate cancer	6.26e-06	5.79e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CB—prostate cancer	6.23e-06	5.77e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ARG2—prostate cancer	6.14e-06	5.68e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PHGDH—prostate cancer	6.14e-06	5.68e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—UMPS—prostate cancer	6.14e-06	5.68e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ACHE—prostate cancer	6.11e-06	5.65e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTT1—prostate cancer	6.11e-06	5.65e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.05e-06	5.6e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.05e-06	5.6e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP2A6—prostate cancer	6.04e-06	5.59e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PLCB2—prostate cancer	6.03e-06	5.58e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—LRP2—prostate cancer	6.03e-06	5.58e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP2C18—prostate cancer	6.03e-06	5.58e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—LDHB—prostate cancer	6.02e-06	5.57e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	6.02e-06	5.57e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—SLC5A5—prostate cancer	6e-06	5.55e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	5.93e-06	5.49e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—P4HB—prostate cancer	5.91e-06	5.47e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP3A5—prostate cancer	5.91e-06	5.47e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—AKR1C3—prostate cancer	5.87e-06	5.44e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP2E1—prostate cancer	5.86e-06	5.42e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PRKACB—prostate cancer	5.84e-06	5.41e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NQO1—prostate cancer	5.79e-06	5.36e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP17A1—prostate cancer	5.78e-06	5.35e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CG—prostate cancer	5.77e-06	5.34e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SLC22A1—prostate cancer	5.75e-06	5.32e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IL2—prostate cancer	5.72e-06	5.3e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.72e-06	5.29e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—TH—prostate cancer	5.71e-06	5.28e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTA3—prostate cancer	5.71e-06	5.28e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—TCN2—prostate cancer	5.71e-06	5.28e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PDHA1—prostate cancer	5.71e-06	5.28e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—UCP3—prostate cancer	5.71e-06	5.28e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.69e-06	5.26e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.67e-06	5.25e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP3A4—prostate cancer	5.65e-06	5.23e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.62e-06	5.2e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SULT2A1—prostate cancer	5.61e-06	5.19e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP1B1—prostate cancer	5.55e-06	5.14e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—MED12—prostate cancer	5.51e-06	5.1e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NCOA2—prostate cancer	5.51e-06	5.1e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GNG5—prostate cancer	5.47e-06	5.06e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—INS—prostate cancer	5.46e-06	5.06e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HSD3B1—prostate cancer	5.45e-06	5.04e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC22A3—prostate cancer	5.45e-06	5.04e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GGT1—prostate cancer	5.38e-06	4.98e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CREBBP—prostate cancer	5.35e-06	4.95e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NCOA1—prostate cancer	5.3e-06	4.9e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NCOA3—prostate cancer	5.27e-06	4.88e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—SLC5A5—prostate cancer	5.26e-06	4.86e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP19A1—prostate cancer	5.22e-06	4.83e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.22e-06	4.83e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTA4—prostate cancer	5.22e-06	4.83e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.18e-06	4.79e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—EP300—prostate cancer	5.14e-06	4.75e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP2E1—prostate cancer	5.13e-06	4.75e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTA2—prostate cancer	5.09e-06	4.71e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NQO1—prostate cancer	5.08e-06	4.7e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CD—prostate cancer	5.07e-06	4.69e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—RXRA—prostate cancer	5.04e-06	4.66e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—HPGDS—prostate cancer	5.03e-06	4.65e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.03e-06	4.65e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ABCG5—prostate cancer	5.03e-06	4.65e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—TH—prostate cancer	5e-06	4.63e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP2C19—prostate cancer	5e-06	4.62e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—SRC—prostate cancer	4.99e-06	4.62e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP3A4—prostate cancer	4.95e-06	4.58e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTA1—prostate cancer	4.91e-06	4.54e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.9e-06	4.54e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTT1—prostate cancer	4.88e-06	4.51e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ACHE—prostate cancer	4.88e-06	4.51e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP1B1—prostate cancer	4.87e-06	4.5e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—VEGFA—prostate cancer	4.86e-06	4.5e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—COMT—prostate cancer	4.86e-06	4.49e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTO1—prostate cancer	4.85e-06	4.49e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.85e-06	4.49e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NAT2—prostate cancer	4.85e-06	4.49e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTP1—prostate cancer	4.83e-06	4.47e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP2A6—prostate cancer	4.82e-06	4.46e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.8e-06	4.44e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—NOS3—prostate cancer	4.79e-06	4.43e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ITPR1—prostate cancer	4.75e-06	4.4e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GGT1—prostate cancer	4.71e-06	4.36e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—AKR1C3—prostate cancer	4.69e-06	4.34e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.68e-06	4.33e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PRKACB—prostate cancer	4.66e-06	4.32e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.65e-06	4.31e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—LRP2—prostate cancer	4.65e-06	4.31e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PLCB2—prostate cancer	4.65e-06	4.31e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NCOA1—prostate cancer	4.64e-06	4.3e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP17A1—prostate cancer	4.62e-06	4.27e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP19A1—prostate cancer	4.58e-06	4.23e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—P4HB—prostate cancer	4.56e-06	4.22e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.55e-06	4.21e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—TYMS—prostate cancer	4.49e-06	4.16e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TGFB1—prostate cancer	4.46e-06	4.13e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GSTM1—prostate cancer	4.44e-06	4.11e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC22A1—prostate cancer	4.44e-06	4.11e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CB—prostate cancer	4.42e-06	4.09e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—RXRA—prostate cancer	4.42e-06	4.09e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NCOA2—prostate cancer	4.4e-06	4.07e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PTGS2—prostate cancer	4.38e-06	4.05e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—LPL—prostate cancer	4.36e-06	4.03e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.33e-06	4e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—MED12—prostate cancer	4.26e-06	3.94e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—COMT—prostate cancer	4.25e-06	3.94e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTP1—prostate cancer	4.23e-06	3.92e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GNG5—prostate cancer	4.22e-06	3.91e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP1A1—prostate cancer	4.21e-06	3.9e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—SLC5A5—prostate cancer	4.2e-06	3.88e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—ERCC2—prostate cancer	4.18e-06	3.86e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ITPR1—prostate cancer	4.17e-06	3.86e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—KRAS—prostate cancer	4.13e-06	3.83e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP2E1—prostate cancer	4.1e-06	3.79e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NCOA3—prostate cancer	4.07e-06	3.76e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NQO1—prostate cancer	4.05e-06	3.75e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—TH—prostate cancer	3.99e-06	3.7e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.97e-06	3.67e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP3A4—prostate cancer	3.95e-06	3.66e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—TYMS—prostate cancer	3.94e-06	3.64e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.93e-06	3.64e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—MTHFR—prostate cancer	3.92e-06	3.63e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GSTM1—prostate cancer	3.89e-06	3.6e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP1B1—prostate cancer	3.89e-06	3.6e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—HPGDS—prostate cancer	3.88e-06	3.59e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.86e-06	3.57e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PPARA—prostate cancer	3.85e-06	3.56e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PTEN—prostate cancer	3.82e-06	3.54e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—LPL—prostate cancer	3.82e-06	3.53e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—PIK3CA—prostate cancer	3.8e-06	3.52e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTT1—prostate cancer	3.76e-06	3.48e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ACHE—prostate cancer	3.76e-06	3.48e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GGT1—prostate cancer	3.76e-06	3.48e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.72e-06	3.44e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NCOA1—prostate cancer	3.71e-06	3.43e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP1A1—prostate cancer	3.69e-06	3.41e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TP53—prostate cancer	3.67e-06	3.4e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—ERCC2—prostate cancer	3.66e-06	3.39e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP19A1—prostate cancer	3.65e-06	3.38e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—EP300—prostate cancer	3.64e-06	3.37e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CAV1—prostate cancer	3.62e-06	3.35e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.62e-06	3.35e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PRKACB—prostate cancer	3.6e-06	3.33e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.56e-06	3.3e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—RXRA—prostate cancer	3.53e-06	3.26e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.46e-06	3.2e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—MTHFR—prostate cancer	3.44e-06	3.18e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.43e-06	3.17e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—COMT—prostate cancer	3.4e-06	3.14e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NCOA2—prostate cancer	3.39e-06	3.14e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTP1—prostate cancer	3.38e-06	3.13e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PPARA—prostate cancer	3.37e-06	3.12e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ITPR1—prostate cancer	3.33e-06	3.08e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CG—prostate cancer	3.3e-06	3.05e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.27e-06	3.03e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.24e-06	3e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CAV1—prostate cancer	3.17e-06	2.94e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.16e-06	2.93e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—TYMS—prostate cancer	3.14e-06	2.91e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NQO1—prostate cancer	3.13e-06	2.89e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—INS—prostate cancer	3.12e-06	2.89e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GSTM1—prostate cancer	3.11e-06	2.87e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—AKT1—prostate cancer	3.1e-06	2.87e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—TH—prostate cancer	3.08e-06	2.85e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CREBBP—prostate cancer	3.06e-06	2.83e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—LPL—prostate cancer	3.05e-06	2.82e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP1B1—prostate cancer	3e-06	2.77e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.94e-06	2.72e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—ERCC2—prostate cancer	2.92e-06	2.7e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GGT1—prostate cancer	2.9e-06	2.69e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CD—prostate cancer	2.9e-06	2.68e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CG—prostate cancer	2.89e-06	2.67e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NCOA1—prostate cancer	2.86e-06	2.65e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.82e-06	2.61e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—MTHFR—prostate cancer	2.75e-06	2.54e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NOS3—prostate cancer	2.74e-06	2.53e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—INS—prostate cancer	2.73e-06	2.53e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—RXRA—prostate cancer	2.72e-06	2.52e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PIK3CA—prostate cancer	2.7e-06	2.49e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PPARA—prostate cancer	2.69e-06	2.49e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CREBBP—prostate cancer	2.68e-06	2.48e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—COMT—prostate cancer	2.62e-06	2.43e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTP1—prostate cancer	2.61e-06	2.41e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ITPR1—prostate cancer	2.57e-06	2.38e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CD—prostate cancer	2.54e-06	2.35e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CAV1—prostate cancer	2.53e-06	2.34e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CB—prostate cancer	2.53e-06	2.34e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PTGS2—prostate cancer	2.5e-06	2.32e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—TYMS—prostate cancer	2.43e-06	2.24e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.42e-06	2.24e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NOS3—prostate cancer	2.4e-06	2.22e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GSTM1—prostate cancer	2.4e-06	2.22e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—LPL—prostate cancer	2.35e-06	2.18e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.31e-06	2.13e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.27e-06	2.1e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—ERCC2—prostate cancer	2.25e-06	2.09e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CB—prostate cancer	2.21e-06	2.05e-05	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—AKT1—prostate cancer	2.2e-06	2.04e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTGS2—prostate cancer	2.19e-06	2.03e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PTEN—prostate cancer	2.18e-06	2.02e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—INS—prostate cancer	2.18e-06	2.02e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CREBBP—prostate cancer	2.14e-06	1.98e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—MTHFR—prostate cancer	2.12e-06	1.96e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—EP300—prostate cancer	2.08e-06	1.93e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PPARA—prostate cancer	2.08e-06	1.92e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.03e-06	1.88e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CAV1—prostate cancer	1.95e-06	1.81e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NOS3—prostate cancer	1.91e-06	1.77e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PTEN—prostate cancer	1.91e-06	1.77e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—EP300—prostate cancer	1.82e-06	1.69e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.78e-06	1.65e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.77e-06	1.64e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTGS2—prostate cancer	1.75e-06	1.62e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—INS—prostate cancer	1.68e-06	1.56e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CREBBP—prostate cancer	1.65e-06	1.53e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.56e-06	1.45e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PIK3CA—prostate cancer	1.54e-06	1.43e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PTEN—prostate cancer	1.53e-06	1.41e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NOS3—prostate cancer	1.48e-06	1.37e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—EP300—prostate cancer	1.46e-06	1.35e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.36e-06	1.26e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTGS2—prostate cancer	1.35e-06	1.25e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PIK3CA—prostate cancer	1.35e-06	1.25e-05	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—AKT1—prostate cancer	1.26e-06	1.16e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PTEN—prostate cancer	1.18e-06	1.09e-05	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—EP300—prostate cancer	1.12e-06	1.04e-05	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—AKT1—prostate cancer	1.1e-06	1.02e-05	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.08e-06	9.97e-06	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—AKT1—prostate cancer	8.8e-07	8.14e-06	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PIK3CA—prostate cancer	8.31e-07	7.69e-06	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—AKT1—prostate cancer	6.79e-07	6.29e-06	CbGpPWpGaD
